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Abstract 
Background: Patients unable to self-report pain are at increased risk for inadequate pain management 
and less than optimal outcomes. The implementation of behavioral pain scales, such as the Critical-Care 
Pain Observation Tool (CPOT), have demonstrated an improvement in pain management and patient 
outcomes. 
Local Problem:  A lack of the routine use of behavioral pain scales for mechanically ventilated patients 
unable to self-report pain was identified as a significant barrier to optimal pain and agitation management.    
Methods: A retrospective pre and post design was used to evaluate the effectiveness and impact of a 
CPOT quality initiative on the management of pain, agitation and patient outcomes.  Descriptive data for 
analysis were extracted from 60 electronic medical records, 30 for both the pre- and post-implementation 
groups.   
Interventions: The quality initiative included training sessions, unit champions, clinical support tools and 
the incorporation of the CPOT into unit pain management guidelines and several analgesic order sets.   
Results: CPOT pain assessments (p<.001) were more frequent in the post-implementation group.  There 
number of PRN analgesics were found to be greater in the post-implementation group, while the tendency 
for the total morphine equivalent dosage was lower.  No differences were found between the pre- and 
post-implementation groups with regard to sedation and agitation management and patient outcomes.  
Conclusions:  The quality initiative was successful in increasing the routine use of the CPOT.  Pain 
management of mechanically ventilated patients in this critical setting improved.  Multidisciplinary 
participation and unit champions were vital to the success of this quality initiative.   
 
Keywords: pain, critical care, critical-care pain observation tool, CPOT, pain management 
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Evaluation of a Critical-Care Pain Observation Tool Quality Initiative 
Introduction 
Pain is an unpleasant sensory and emotional experience that is a major source of stress for critical 
care patients1-6.  Over 75% of intensive care patients will experience pain during their intensive care 
admissions, with 50-74% of these patients experiencing moderate to severe pain4,7,8.  Contributing factors 
to pain have been identified as the sequelae of acute illness, traumatic injury, surgery, cancer, invasive 
equipment, nursing and medical interventions and procedures, and immobility9,10. 
The inappropriate management of pain accelerates the stress response that can lead to a cascade 
of deleterious psychological and physiologic consequences9.  Psychologically, uncontrolled pain can lead 
to sleep deprivation, exacerbation of agitation and delirium, and post-traumatic stress disorder9,11.  
Physiological pain results in an endogenous catecholamine stress response that may result in multiple 
organ dysfunction11,12.  Negative outcomes associated with inadequate pain management include 
prolonged mechanical ventilation, longer lengths of stay in intensive care units (ICU), an increased risk of 
morbidity and mortality, a decrease in quality of life, and an increased risk of developing a chronic pain 
syndrome12-16.   
Barriers to pain management include the patient’s inability to communicate verbally, life-
threatening illness or injury, concerns about opioid addiction or abuse, lack of pain management 
education for nurses and providers, validity and inconsistency in pain management protocols, and other 
individual and system-related barriers17,18.  These barriers and the sequel of results have contributed to the 
more than $300 billion U.S. health care dollars spent on pain management annually and approximately 
$335 billion dollars associated with lost productivity directly attributed to the presence of pain19. 
Background 
 The rationale for providing appropriate pain relief is to decrease the severity and frequency of the 
physical and emotional effects of pain and to minimize the adverse effects of pain management10,18.  In 
2011, the International Association for the Study of Pain (IASP) issued a statement acknowledging pain 
management as a fundamental human right20.  The first step in pain management is the appropriate and 
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routine assessment of the presence and severity of pain9,21,22.  The best patient outcomes are achieved 
when pain management strategies are tailored to the individual patient’s needs21,22.   The most vulnerable 
population for inadequate pain management are individuals that are unable to self-report the presence of 
pain.   
Within adult ICUs, more than one-third of critically ill patients are unable to self-report the 
presence of pain23.  In addition, 40% of the adult intensive care patients who are able to self-report the 
presence of pain find it somewhat to extremely difficult to do so when utilizing a self-rating scale such as 
the Numeric Rating Scale (NRS)23.  Therefore, nearly 60% of adult intensive care patients may benefit 
from a behavioral pain scale, such as the Critical-Care Pain Observation Tool (CPOT).  
Behavioral pain scales, such as the CPOT, are recommended instruments for pain assessment and 
management in adult patients who are unable to self-report pain9,24-26. Benefits of implementing 
behavioral pain scales include an increase in pain assessments, an increase in documentation, a decrease 
in episodes of severe pain, and an increase in patient satisfaction with pain management15,27-30.  The 
implementation of the CPOT has also demonstrated an improvement in the effectiveness of pain 
management strategies, a decrease in the number of patient complications, and a consistent relationship in 
decreasing the duration of mechanical ventilation and ICU length of stay17,24,27,29.  
Local Problem 
 A lack of routine pain assessments and documentation was identified as a significant barrier to 
adequate patient care coordination and consistency of pain and agitation management in a small, 13 bed, 
medical-surgical ICU.  It was observed that current management practices for agitation and anxiety 
focused largely on the administration of sedatives with limited attention being placed on causative factors, 
such as pain. 
To address the identified gaps, the clinical care team chose an “address pain first” approach, in 
line with the PAD and Sedation and Analgesia by Non-Anesthesiologists guidelines 1,9,26.  A 
multidisciplinary quality initiative committee was formed and charged with the task of developing and 
implementing unit pain management guidelines.  After conducting a historical review of patient clinical 
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characteristics and pain assessment practices, a gap in the application of reliable and valid behavioral pain 
scales was identified.  The CPOT was selected as the recommended behavioral pain scale and a quality 
initiative workgroup was established.   
Purpose 
 The purpose of this project was to evaluate the effectiveness of the CPOT quality initiative among 
adult, mechanically ventilated patients in the medical-surgical ICU.  
The specific aims of this project were to: 
1. Assess the use of the CPOT among the ICU staff nurses pre- and post-implementation of the 
CPOT quality initiative. 
2. Examine the effects of using the CPOT to guide the use of PRN opioid medications for pain 
management. 
3. Examine the effects of using the CPOT to guide the use of analgesics and the resulting effect 
on the total daily average morphine equivalent dosage. 
4. Examine patient outcomes (i.e., length of mechanical ventilation, ICU length of stay, 
episodes of severe pain, and all-cause mortality) and clinical measures (i.e., average level of 
sedation, incidences of moderate to deep levels of sedation, and incidences of agitation as 
assessed by the Richmond Agitation and Sedation Scale [RASS]) pre- and post-
implementation of the CPOT quality initiative.  
Methods 
Context 
The CPOT quality initiative evaluation was conducted at a small academic medical center serving 
more than 83,000 patients, located in the southeastern United States.  The ICU is a combined medical-
surgical unit comprised of 13 beds, with an average annual census of nearly 2000 patients.  The historical 
monthly census for mechanically ventilated patients is 33 patients.  The unit care team consists of 36 
registered nurses and a combined medical-surgical specialty provider group made up of medical doctors, 
advanced practice registered nurses, and pharmacists serving approximately 54 medical patients and 36 
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surgical patients per month. All patients admitted to the ICU are over the age of 18 and the unit includes 
both male and female patients. 
Intervention 
The practice change model used to guide the quality initiative was the model for evidence-based 
practice change developed by J. H. Larrabee31.  A multidisciplinary clinical care team was established and 
a comprehensive literature review was conducted.  The multidisciplinary clinical care team members 
chose to follow the ICU Liberation: Assess, Prevent, and Manage Pain recommendations, a component of 
the ABCDEF care bundle, to develop unit practice pain assessment and management guidelines.  Based 
on historical clinical characteristics of the patients served and feasibility of use by nurses, the CPOT was 
chosen as the recommended behavioral pain scale for patients who are unable to self-report pain.   
Previous studies have demonstrated the reliability and validity of the CPOT for identifying 
behaviors associated with pain in the mechanically ventilated adult without a brain injury who is unable to 
self-report pain25,32-35.  The instrument was derived from a compilation of previously established pain 
assessment instruments, chart reviews of critically ill patients, and focus groups involving critical care 
nurses and physicians25.   The CPOT is comprised of four behavioral categories: facial expression, body 
movements, muscle tension, and compliance with the ventilator for intubated patients or vocalization for 
extubated patients25.  Each category is scored from 0 to 2 with a total possible score ranging from 0, 
equaling no pain, to 8, being the highest level of pain25. 
The CPOT quality initiative included the incorporation of the CPOT into unit practice pain 
management guidelines (See Figure 1) and several analgesic order sets, such as a fentanyl PRN and 
infusion order set for mechanically ventilated patients (See Figure 2).  The unit practice pain management 
guideline design was modeled after the Pain Intervention Algorithm developed by Dr. Gélinas36.  Prior to 
the unit wide implementation of the CPOT, the intensive care staff nurses, providers, and nursing 
leadership team attended a 60-minute instruction and application session on CPOT driven pain 
assessments and management.  The education initiative included videos provided by Dr. Gélinas, the 
developer of the CPOT, introduction and discussion on the newly developed unit practice pain 
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management guidelines and analgesic order-sets, and a hands-on simulated clinical experience designed 
to improve competency of CPOT pain assessments37,38.   Enlarged versions of the CPOT and a visually 
enlarged horizontal numeric rating scale (NRS), obtained from the Society of Critical Care Medicine, was 
placed in unit reference binders in each patient care room37.  Unit champions were available to the clinical 
care team throughout the implementation period.  The role of the unit champions was to ensure clinical 
competency of CPOT pain assessments and pain management expectations as outlined in unit practice 
guidelines. The education initiative occurred over a one-month period.  
The visually enlarged horizontal NRS was determined to be the most appropriate self-reporting 
pain scale for the patient population served.  Its validity and feasibility for ICU patients was demonstrated 
by Chanques and colleagues39.  The NRS has a range of 0 to 10 with word anchors of “no pain” at the 
zero end of the scale and “extreme pain” at the opposite end of the scale, designated as a score of 1037.  
The unit multidisciplinary care team was already in the practice of utilizing the NRS for assessing pain in 
patients able to self-report.  Therefore, only a limited amount of emphasis was placed on the use of the 
visually enlarged horizontal NRS during the education initiative.  
Study of the Intervention 
 A retrospective pre and post descriptive design was used to evaluate the effectiveness and impact 
on patient outcomes and clinical measures for pain management, sedation, and agitation of the CPOT 
quality initiative.  Descriptive data for analysis were extracted from electronic medical records (EMRs).  
Based on historical census data and patient clinical characteristics (i.e., ICU length of stay, length of 
mechanical ventilation, and primary diagnoses) a total of 60 EMRs were included for analysis of the 
CPOT quality initiative, 30 pre-implementation and 30 post-implementation.  The pre-implementation 
review period was six months prior to the development of the CPOT quality initiative workgroup.  The 
post-implementation review period was the six month period following the completion of the CPOT 
education initiative.   
Medical record inclusion for the project consisted of patients meeting the following criteria: ICU 
length of stay (LOS) ≥ 72 hours and length of mechanical ventilation ≥ 24 hours.  Patient medical records 
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were excluded from the project if the patient had a spinal injury or a Glasgow Coma Scale (GCS) score < 
4 prior to sedation, or if they received neuromuscular blocking agents (NMBA) prior to or during the first 
72 hours post-intubation.  Patients were excluded for these reasons due to few reliability and validity 
studies related to the use of the CPOT in these patient populations25.   
 EMRs were randomly selected from the list of patients admitted to the medical-surgical ICU 
within the designated review periods, until the investigators reached a total of 60 eligible EMRs.  Each 
ICU admission for a patient was considered a discrete event.  Therefore, a patient’s comprehensive EMR 
may have been selected for review multiple times.  The first 30 EMRs from each of the designated review 
periods that met the inclusion and exclusion criteria were included in the project for a sample total of 60 
EMRs.   
Measures 
 Demographic data were collected from the EMR from the time of admission.  Clinical data used 
to characterize the sample and to identify any potential confounding variables are related to the patient’s 
condition from ICU admission until the end of the mechanical ventilation observation period, with the 
exception of the Acute Physiology and Chronic Health Evaluation (APACHE) II Score.  Clinical data 
used to calculate APACHE II Scores were related to the patient’s condition within the first 24 hours of the 
ICU admission.  The APACHE II Score calculator at www.medscape.com was utilized to calculate the 
APACHE II Score40.   
Clinical pain assessments and their effects on pain management, clinical measures, and patient 
outcomes were based on the first full intubation day (midnight to midnight) during the patient’s first 
intubation period.  An intubation period was calculated in total hours from the time of intubation until 
extubation.  Re-intubations within one hour of an extubation were not considered new intubations and 
were counted as part of the total time for the first intubation period.  The patient’s length of mechanical 
ventilation is based on the patient’s first intubation period for that ICU admission.  The patient’s ICU 
length of stay was calculated from the recorded date and time of admission to the ICU until the recorded 
date and time of discharge or transfer from the ICU or death of the patient.   
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Variables related to patient demographics, pain assessments and management, clinical measures, 
and patient outcomes were documented utilizing a chart audit tool developed by the authors.  The chart 
audit tool was designed to follow the flow and output of data inquiries of the patient EMRs.  To ensure a 
comprehensive review of the patient’s EMR, data were collected from each of the two electronic health 
information record systems used to capture various aspects of the patients medical care.  Variable data in 
each of the electronic health information record systems were treated as discrete data.   
Pain assessment variables included the frequency of pain assessments, frequency of CPOT 
assessments, and frequency of patient’s inability to self-report pain.  Glasgow Coma Scale (GCS) verbal 
response subscale scores of 3 or less were used as a surrogate marker for the patient’s inability to self-
report the presence of pain.  Pain management variables included the frequency of PRN, scheduled 
intermittent, and continuous infusion analgesics, type and route of administration, and total opioid 
analgesic dosages.  The opioid analgesic dosages were collected and then converted into the morphine 
equivalent dosage for comparative purposes.    
To identify confounding variables for pain management practices and patient outcomes (i.e., 
length of mechanical ventilation, ICU length of stay, episodes of severe pain, and all-cause mortality), 
patient demographic data, ICU diagnoses, APACHE II scores, and sedation and agitation variables were 
extracted from each patient’s EMR.  The type and frequency of sedatives were collected along with 
related clinical measures (i.e., average levels of sedation for manipulations of time and incidences of 
moderate to deep sedation).  CPOT pain scores of 6 or greater and NRS scores of 7 or greater were 
considered clinical indicators of severe pain.  RASS scores of -3 or less were captured as incidences of 
moderate to deep sedation.  Incidences of agitation were identified by documented RASS scores of +2 or 
greater.  Documented positive CAM-ICU scores were used to evaluate the frequency of delirious 
episodes.  
Analysis 
 All data analyses were conducted using SPSS version 23.0 (SPSS Inc., Chicago, Illinois).  A p 
value of < .05 was considered statistically significant.  Frequency distributions were conducted for all 
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variables to detect and correct erroneous data.  Descriptive statistics were conducted, such as frequencies 
and means ± standard deviations for all variables in the both the pre- and post-implementation group, as 
appropriate to the level of measurement of the variable.  Independent sample t-tests were used to compare 
parametric data (i.e. age, APACHE II scores, frequency of pain assessments, patient’s ability to self-
report pain, administrations of PRN analgesics, and levels of sedation).  Chi-square (x2) statistics were 
used for nonparametric nominal variables (i.e., gender, race, clinical demographic characteristics, and 
number of pain assessments, administrations of analgesics and sedatives, and episodes of moderate-deep 
sedation, agitation, severe pain, and all-cause mortality). The Mann-Whitney U test was used for 
nonparametric continuous variables (i.e., total morphine equivalent dosage, length of mechanical 
ventilation, and ICU length of stay).  
Significant differences for pain assessment and management variables and patient outcomes were 
expected between the pre- and post-implementation groups.  Specifically, it was hypothesized that the 
frequency of pain assessments and PRN administrations of analgesics would be higher in the post-
implementation group, but the morphine equivalent dosages would be lower.  It was also hypothesized 
that patients would experience fewer episodes of moderate to deep levels of sedation, agitation, and 
severe pain, and improved patient outcomes (i.e., decreases in length of mechanical ventilation, ICU 
length of stay, and all-cause mortality).  
Ethical Considerations 
Data retrieved were de-identified through the assignment of unique patient project numbers and 
recorded using a chart audit tool.  A waiver for the documentation of informed consent was obtained 
along with the approval for the project from the medical center’s institutional review board.  
Results 
Characteristics of the Sample 
 A total of 204 EMRs (91 for the pre-implementation group and 113 for the post-implementation 
group) were screened for inclusion and exclusion criteria.  The final project sample size included 60 
EMRs (30 EMRs for each of the designated review periods).  The sociodemographic characteristics of the 
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patients in both groups are described in Table 1.  Patients included in the project were mostly male 
(96.7%), Caucasian (90.0%), and an average age of 69 years.  Clinical demographics of the patients are 
described in Table 2.  Patients included in the project were largely medical patients (85.0%), had an 
average APACHE II score of 19.78, and were generally conscious at the time of their ICU admission 
(62.0%).  The top three ICU diagnoses included respiratory compromise (61.7%), cardiovascular 
compromise (41.7%), and sepsis (35.0%).  Greater than 50% of the patients had a medical history of 
diabetes and chronic pain, with nearly 50% experiencing chronic neuropathy.  No significant differences 
were identified between the two groups in regards to patient sociodemographic or clinical demographic 
variables.  In addition, there was no statistical difference in the discharge status between the two groups.  
Overall, the pre- and post-implementation groups were similar.  
Frequency of Pain Assessments 
 Each of the patients included in the project received at least one pain assessment during the 
observation period (See Table 3).  Patients in the post-implementation group were assessed 1.5 times 
more frequently (M = 7.10, SD = 5.09) than the patients in the pre-implementation group (M = 4.5, SD = 
2.00).  The difference between the two groups was found to be statistically significant (t (37.70) = -2.60, p 
= .013, two-tailed) with a moderate to large (eta squared = .104) magnitude of differences in the means 
(mean difference = -2.60, 95% CI: -4.62 to -.58).  In addition, the patients in the post-implementation 
group received 7.6 times more CPOT pain assessments (M = 4.03, SD = 2.80) than the patients in the pre-
implementation group (M = .53, SD = 1.01).  The difference between the mean frequency of CPOT pain 
assessments between the two groups was found to be statistically significant (t (36.41) = -6.45, p = .000, 
two-tailed) with a large (eta squared = .418) magnitude of differences in the means (mean difference = -
3.5, 95% CI: -4.60  to -2.40), while the frequency of self-reported pain assessments was found to be 
similar.  In addition, the percent of time the patients were determined to be unable to self-report their pain 
was not found to be comparable, as no difference was detected between the pre- and post-implementation 
groups.  
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Effects on Pain Management (Administration of Pharmacological Interventions) 
 The number of patients that received analgesics in both the pre- and post-implementation groups 
was comparable (See Table 4).  The patients in the post-implementation group received twice as many 
PRN analgesics (M = 1.03, SD = 2.17) as those in the pre-implementation group (M = .53, SD = 1.41).  
However, no statistical difference was detected between the two groups (t (49.69) = -1.06, p = .295, two-
tailed).  The number of patients that were administered either scheduled or continuous analgesics were 
also comparable (x2 (1, n = 60) = .65, p = .422, phi = .14), with the most common analgesic administered 
in both groups being fentanyl (IV).  The mean total morphine equivalent dosage in the post-
implementation group (M = 61.80, SD = 68.64) was less than the pre-implementation group (M = 84.63, 
SD = 164.25).  However, the Mann-Whitney U Test revealed no significant difference (U = 497, z = .708, 
p = .479, r = .09).  
Effects on Sedation and Agitation 
 The number of patients who received sedatives in both the pre- and post-implementation groups 
was comparable, as was the average percent of time patients were sedated (See Table 5).  There was no 
significant difference identified for the mean RASS scores of patients while intubated during the review 
period between the two groups.  Twice as many episodes of moderate to deep sedation (n = 14) and 
agitation (n = 8) were identified in the post-implementation group as opposed to the pre-implementation 
group (n = 6, moderate to deep sedation; n = 3, agitation).  However, these results were not significantly 
different.  
Patient Outcomes 
 Patient outcomes, in regards to length of mechanical ventilation, length of ICU stay, and all-cause 
mortality, were comparable between the pre- and post-implementation groups (See Table 6).  Five times 
as many episodes of severe pain were identified in the post-implementation group (5 vs 36).  However, 
this difference did not yield a statistical difference (x2 (6, n = 60) = 8.05, p = .234, phi = .37). 
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Discussion 
 The implementation of valid behavioral pain scales such as the CPOT, designed for patients 
unable to self-report pain, has been associated with an improvement in pain management and the 
efficiency of pharmacological interventions15,17,27,29,41,42.  In addition, the routine use of behavioral pain 
scales has been associated with shorter lengths of mechanical ventilation and ICU lengths of 
stay15,27,29,41,43.  The purpose of this quality initiative evaluation was to assess the impact of implementing 
the CPOT on pain assessments and management, clinical measures for sedation and agitation, and patient 
outcomes.  As hypothesized, there was a significant increase in the frequency of pain assessments and a 
tendency towards the improvement in pain management practices between the pre- and post-
implementation groups.  In contrast, the expected improvements in clinical measures for sedation and 
agitation were not realized.  In addition, there was no significant difference identified between the two 
groups for the assessed patient outcomes.  
 The implementation of the CPOT quality initiative created an increase in the frequency of pain 
assessments documented by nursing staff in this critical care environment, with an explicit increase in the 
frequency of CPOT assessments.  There was no difference between the pre- and post-implementation 
groups for the number of patient self-reported pain assessments and the percentage of time the patients 
were determined to be unable to self-report their pain.  Because there were no differences identified 
between the two groups, we believe the nursing staff was using the CPOT for pain assessment in the 
appropriate patient scenarios.  These results are consistent with those of Arbour et al., who reported an 
increase in the mean frequency of pain assessments from 4.33 to 12.33 (p < .001) and an increase in the 
mean number of painful episodes from 1.13 to 4.27 (p < .001), six months after a CPOT implementation 
project27.  Similar findings were reported by Rose et al. in a multi-ICU, single academic hospital.  They 
reported  an increase in the documentation of pain assessments from 180 to 341 (p < .001) in a 
cardiovascular ICU patient group and from 213 to 516 (p < .001) in a mixed medical-surgical ICU29.  In 
addition, these investigators identified a specific increase in the documentation of behavioral pain 
assessments from 130 to 147 (p < .001) in the cardiovascular ICU patient group29.    
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 The EMR evaluation for analgesic interventions revealed a tendency towards an increase in the 
utilization of PRN analgesics and a decrease in the mean morphine equivalent dosage.  While these 
results were not found to be significantly different in our project evaluation, they are similar to the 
findings reported by Arbour et al. and Rose et al.  In addition, Wibbenmeyers et al. reported an increase in 
opioid administration with higher CPOT scores42.  An increase in the use of PRN analgesics with an 
increase in the identification of episodes of severe pain appears to be a similar result of implementation of 
CPOT for pain management in the critical care setting.  These findings, in combination with an increase 
in the frequency of documented CPOT assessments, suggest that the clinical team are utilizing the CPOT 
instrument appropriately.  
 Our project’s results from the use of the CPOT as a tool for improvement in sedation and 
agitation management are incongruent with those reported by Luckey et al. and Chanques et. al..  Luckey 
et al. reported a decreasing tendency in the average daily sedative doses for propofol, lorazepam, 
midazolam, and dexmedetomidine after transitioning from the use of the Face, Legs, Activity, Cry, and 
Consolability (FLACC) scale to the use of the CPOT instrument43.  However, the effects of lower dosages 
of sedatives on the patient’s level of sedation or episodes of agitation were not assessed.  Chanques et al. 
reported a decrease in the incidences of agitation, 29 vs. 12% (p = .002) with the implementation of the 
Behavioral Pain Scale (BPS) in mechanically ventilated ICU patients.  However, there are relevant 
psychometric differences between the BPS and the CPOT that may account for the differences in effects 
on episodes of agitation.  Our project is the first to provide results on the implementation of the CPOT 
and its effects on levels of sedation and episodes of agitation.  Further studies are needed to fully evaluate 
the full effect of CPOT-driven pain management practices on the management of sedation and agitation.  
 The CPOT quality initiative did not appear to have an effect on patient outcomes as measured by 
length of mechanical ventilation, ICU length of stay, and all-cause mortality.  While Arbour et al. 
reported a tendency toward lower lengths of mechanical ventilation and ICU lengths of stay, these results 
have not been repeated nor reported consistently in other studies27.  Rose et al. found a decrease in ICU 
length of stay from 2.0 to 1.8 days (p = .007) in the cardiovascular ICU group but no differences were 
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reported between the mixed medical-surgical ICU groups29.  In addition, Rose et al. found no difference 
in the length of mechanical ventilation among either ICU patient groups29.  Our findings were also 
congruent with Luckey et al.’s (2015) findings of no statistical difference in the length of mechanical 
ventilation and ICU length of stay following implementation of the CPOT43.  Our project is the first to 
analyze the correlation between implementation of the CPOT and its effects on all-cause mortality.  All-
cause mortality is a definitive patient outcome indicative of the total state of the healthcare system and 
should therefore be considered as an outcome measure in future studies.  
Limitations 
 The small sample size limits the generalizability of these project results.  In addition, limitations 
within the project design and confounding clinical factors may have influenced the internal validity of the 
project.  First, it is possible that clinical data were over represented in the project because of potential for 
duplication in the charting within the two electronic health information record systems.  This 
measurement bias was considered acceptable in order to create a comprehensive clinical picture and avoid 
implementing any researcher bias in the data collection process.  Second, the time span between the pre-
implementation review period and the post-implementation period was one year.  While this design was 
intentional to avoid capturing any influence of the CPOT quality initiative workgroup in the pre-
implementation group, the influence of other implemented quality initiatives over the year were not 
isolated as confounding variables within the post-implementation group and may have influenced the 
internal validity of the project.  In addition, a new chief of critical care was on-boarded during the six 
month post-implementation review period.  The change in patient care management and support for the 
CPOT quality initiative may have compromised the external validity of the project.   
Conclusions  
Patients who are mechanically ventilated and unable to self-report their pain are at high risk for 
inadequate pain relief and less than optimal outcomes.  Behavioral pain scales, such as the CPOT, have 
been shown to be effective in improving pain management strategies.  The implementation of our quality 
initiative resulted in increased and appropriate use of the CPOT to augment clinical nursing practice for 
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pain management.  Based on our success, we recommend similarly designed projects testing the 
utilization and effectiveness of the CPOT in larger samples and in different critical care environments to 
further assess the relationships between the use of behavioral pain scales and clinical outcomes.  
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Tables 
Table 1. Sociodemographic Characteristics of the Sample (N = 60) 
 
 
Variable 
Pre-
implementation 
Group (n = 30) 
Post- 
implementation 
Group (n = 30) 
 
Total          
(N = 60) 
Statistical 
Test 
     x2                 t 
Gender, n    1.000*  
   Male 29 (96.7%) 29 (96.7%) 58 (96.7%)   
   Female 1 (3.3%) 1 (3.3%) 2 (3.3%)   
      
Race, n    .304   
   Caucasian 29 (96.7%) 25 (83.3%) 54 (90.0%)   
   African American 0 2 (6.7%) 2 (3.3%)   
   Hispanic 0 0 0   
   Non-Hispanic 0 1 (3.3%) 1 (1.7%)   
   Not Specified 1 (3.3%) 2 (6.7%) 3 (5.0%)   
      
Age, mean (SD) 69.03 (±7.41) 70.67 (±9.74) 69.85 (±8.62)  .468 
      
Legend:  x2 = Chi-square statistics, t = Independent sample t-tests 
* Fisher Exact Test 
a p < 0.5, statistically significant difference between the pre- and post-implementation groups 
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Table 2. Clinical Characteristics of the Sample (N = 60) 
 
 
Variable 
Pre-
implementation 
Group (n = 30) 
Post- 
implementation 
Group (n = 30) 
 
Total          
(N = 60) 
    Statistical    
    Test 
     x2                t 
Provider Service, n    1.000*  
   Medical 25 (83.3%) 26 (86.7%) 51 (85.0%)   
   Surgical 5 (16.7%) 4 (13.3%) 9 (15.0%)   
      
APACHE II Score, 
mean (SD) 18.47 (±5.77) 21.10 (±7.27) 19.78 (±6.64)  .125 
      
ICU Admission Dx(s)     
   Resp. Comp., n 20 (66.7%) 17 (56.7%) 37 (61.7%) .595  
   Cardio/Vasc     
      Comp., n 13 (43.3%) 12 (40.0%) 25 (41.7%) 1.000  
   Sepsis, n 12 (40.0%) 9 (30.0%) 21 (35.0%) .588  
   Encephalopathy/  
      Stroke, n 4 (13.3%) 8 (26.7%) 12 (20.0%) .333 
 
   Acute Kidney    
      Failure, n  4 (13.3%) 3 (10.0%) 7 (11.7%) 1.000
*  
   Gastrointestinal  
      Comp., n 4 (13.3%) 4 (13.3%) 8 (13.3%) 1.000
*  
   Pancreatic  
      Comp., n  1 (3.3%) 2 (6.7%) 3 (5.0%) 1.000
*  
   Liver Failure , n 1 (3.3%) 1 (3.3%) 2 (3.3%) 1.000*  
      
Medical Hx of:      
   Diabetes    .139  
      (Type II), n 13 (43.3%) 19 (63.3%) 32 (53.3%)   
      (Type I), n 0 1 (3.3%) 1 (1.7%)   
   Chronic  
      Neuropathy, n 13 (43.3%) 15 (50.0%) 28 (46.7%) .796  
   Chronic Pain, n 19 (63.3%) 21 (70.0%) 40 (66.7%) .784  
   Depression  
      Disorder, n 12 (40.0%) 12 (40.0%) 24 (40.0%) 1.000  
   Anxiety Disorder,  
      n  13 (43.3%) 14 (46.7%) 27 (45.0%) 1.000  
   Sleeping  
      Disorder, n 13 (43.3%) 14 (46.7%) 27 (45.0%) 1.000  
   Chronic Opioid  
      Use, n 3 (10.0%) 2 (6.7%) 5 (8.3%) 1.000
*  
   Chronic    
      Benzodiazepine   
      Use, n  
1 (3.3%) 0 1 (1.7%) 1.000*  
      
Legend:  x2 = Chi-square statistics, t = Independent sample t-tests 
* Fisher Exact Test 
a p < 0.5, statistically significant difference between the pre- and post-implementation groups 
Independent sample t-tests 
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Table 2. Clinical Characteristics of the Sample (N = 60) (Continued) 
 
 
Variable 
Pre-
implementation 
Group (n = 30) 
Post- 
implementation 
Group (n = 30) 
 
Total          
(N = 60) 
    Statistical    
    Test 
     x2                t 
   Illicit Drug Use, n 2 (6.7%) 1 (3.3%) 3 (5.0%)   .000*  
   Tobacco Use, n  19 (63.3%) 15 (50.0%) 34 (56.7%)   .434  
   ETOH Abuse, n 5 (16.7%) 6 (20.0%) 11 (18.3%)   .000  
      
Level of Consciousness at the time of ICU admission, n    .104  
   Unconscious    
      (Glasgow ≤ 8) 7 (23.3%) 14 (46.7%) 21 (35.0%) X  
   Conscious    
      (Glasgow ≥ 9) 23 (76.6%) 16 (53.3%) 39 (65.0%)   
      
Discharge Status, n      
   Transferred 20 (66.7%) 19 (63.3%) 39 (65.0%) .581  
   Home 1 (3.3%) 3 (10.0%) 4 (6.7%)   
   Deceased 9 (30.0%) 8 (26.7%) 17 (28.3%)   
      
Legend:  x2 = Chi-square statistics, t = Independent sample t-tests 
* Fisher Exact Test 
a p < 0.5, statistically significant difference between the pre- and post-implementation groups 
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Table 3. Pain Assessment (N = 60) 
 
 
Variable 
Pre- 
implementation 
Group (n = 30) 
Post- 
implementation Group 
(n = 30) 
 
Statistical test 
       x2                     t 
Patients with Pain 
Assessments, n 30 (100%) 30 (100%) 1.000  
     
Pain Assessments, n 135 213 .599  
   CPOT Pain Assessments, n  16 (11.9%) 121 (56.8%) .001a  
   Other Pain Assessments, n  119 (88.1%) 91 (42.7%) .002a  
     
Frequency of any Pain 
Assessments, mean (SD) 4.50 (±2.00) 7.10 (±5.09)  .013
a 
   Frequency of CPOT Pain  
     Assessments, mean (SD) .53 (±1.01) 4.03 (±2.80)  .000
a 
   Frequency of Other Pain  
     Assessments, mean      
     (SD) 
3.97 (±2.14) 3.03 (±4.46)  .307 
    
% Time Patients unable to   
self-report pain, mean (SD) 81.67% (±30.75) 75.83% (±37.99)  .516 
     
Legend:  x2 = Chi-square statistics, t = Independent sample t-tests 
* Fisher Exact Test 
a p < 0.5, statistically significant difference between the pre- and post-implementation groups 
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Table 4. Pain Management (Administration of Pharmacological Interventions), 
(N = 60) 
 
 
Variable 
Pre-
implementation 
Group (n = 30) 
Post- 
implementation 
Group (n = 30) 
 
Statistical Test 
     U              x2                   t 
Patients Administered Analgesics, n     
   Any Analgesics, n 19 (63.3%) 23 (76.7%)  .398  
   PRN Analgesics, n 7 (23.3%) 8 (26.7%)  1.000  
   Continuous Infusion, n 15 (50.0%) 19 (63.3%)  .434  
   Scheduled Analgesic,n 3 (10.0%) 5 (16.7%)  .704  
      
Administrations of 
PRN analgesics, n  16 31  .815 
 
   Fentanyl (IV), n 14 (87.5%) 24 (77.4%)  .625  
   Hydromorphone (IV),  
      n 0 2 (6.5%)  .492
*  
   Morphine (IV), n 0 5 (16.1%)  .355  
   Hydrocodone/ 
      Acetaminophen  
      (PO), n 
1 (6.3%) 0  1.000*  
   Acetaminophen  
      (PO), n 1 (6.3%) 0  1.000
*  
      
Administrations of 
PRN analgesics, mean 
(SD) 
.53 (±1.41) 1.03 (±2.17)   .295 
      
Patients Administered 
Scheduled/Continuous 
Analgesics, n 
17 21  .422  
   Fentanyl (Continuous  
      IV Infusion), n 15 (93.8%) 19 (90.5%)  .434  
   Hydrocodone/   
      Acetaminophen   
      (PO), n 
1 (6.3%) 2 (9.5%)  1.000  
   Oxycodone (PO), n 0 1 (4.8%)  1.000  
   Acetaminophen  
      (PO), n  0 0  1.000  
   Gabapentin (PO), n 2 (12.5%) 2 (9.5%)  1.000  
      
Morphine Equivalent 
Dosage, mean (SD) 84.63 (±164.25) 61.80 (±68.64) .479   
      
Legend: U = Mann-Whitney U test, x2 = Chi-square statistics, t = Independent sample t-tests 
* Fisher Exact Test 
a p < 0.5, statistically significant difference between the pre- and post-implementation groups  
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Table 5. Sedation and Agitation, (N = 60) 
 
 
Variable 
Pre- 
implementation 
Group (n = 30) 
Post- 
implementation 
Group (n = 30) 
 
Statistical Test 
              x2                         t 
Patients Administered  
Sedatives, n  27 (90.0%) 25 (83.3%)            .706
* 
   Propofol, n 21 (77.8%) 21 (84.0%)           1.000 
   Midazolam, n 8 (29.6%) 6 (24.0%)            .760 
   Haldoperidol, n 1 (3.7%) 1 (4.0%)           1.000 
   Dexmedetomidine, n 1 (3.7%) 2 (8.0%)           1.000* 
      
% Time Patients were  
Sedated, mean (SD) 80.0% (±33.09) 72.5% (±39.58)                 .429 
      
RASS while 
intubated, mean (SD) 
(n = 29)                      
-1.35 (±0.99) 
(n = 28)                         
-1.16 (±0.88)           .434 
      
Episodes of moderate-
deep sedation  
(RASS ≤ -3), n 
(n = 29)                     
6 
(n = 28)                      
14 .394  
      
GCS while intubated, 
mean (SD) 
(n = 28)                
9.71 (±2.25) 
(n = 29)                
10.09 (±2.92)           .584 
      
Episodes of Agitation 
(RASS ≥ +2), n 
(n = 29)                     
3 
(n = 28)                        
8 .520  
         
Legend: x2 = Chi-square statistics, t = Independent sample t-tests 
* Fisher Exact Test 
a p < 0.5, statistically significant difference between the pre- and post-implementation groups  
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Table 6. Patient Outcomes, (N = 60) 
 
 
Variable 
Pre- 
implementation 
Group (n = 30) 
Post- 
implementation 
Group (n = 30) 
 
Statistical Test 
            U                  x2                   
Length of Mechanical 
Ventilation (days), 
mean (SD) 
9.38 (±9.35) 9.54 (±7.13)          .615 
      
ICU Length of stay 
(days), mean (SD) 10.91 (±9.49) 10.66 (±8.12)          .935 
      
Episodes of severe 
pain, n 5 (3.7%) 36 (16.9%)            .234 
      
All-Cause Mortality, 
n 9 (30.0%) 8 (26.7%)           .581 
      
Legend: U = Mann-Whitney U test, x2 = Chi-square statistics 
* Fisher Exact Test 
a p < 0.5, statistically significant difference between the pre- and post-implementation groups  
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Unit Pain Management Guideline Algorithms 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.  
 
 
 
 
Pain Assessment Standards of Care 
 
 
Regular Pain Assessment 
(Q 2 hrs and PRN) 
 
- Scale Used 
- Pain Observations as 
needed (i.e. CPOT) 
- Severity Number 
Document all 
pain 
assessments  
Pain Reassessment 
 
- Scale used 
- Severity Number 
- Response to Med 
 
Pain Scale Decision Tree 
  
Comprehensive Pain Assessment 
(Q 4 hrs and PRN) 
 
- Pain Location 
- Acceptable Goal 
- Functional Goal 
- Scale Used 
- Severity Number 
- Pain: Character, Onset 
Date/Time, & Timing 
- Pain Factors: Aggravate 
Factor & Relieving Factor 
 
NO 
NRS: 0-10 
CPOT: 0-8 
Able to Self-Report 
YES 
Unable to Assess 
NO YES 
Paralytics 
Pain Management 
 
- Type of 
Intervention 
• Comprehensive pain assessment Q 4 hours (with every physical assessment) 
• Regular Pain Assessment (NRS or CPOT) with every 2 hrs and PRN 
• Reassessment within 15 to 30 mins of IV/IM pain medication intervention 
• Reassessment within 1 hour of oral pain medication intervention 
• Pre, Intra & Post procedure pain assessments 
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Figure 1 (continued).  
 
 
 
 
 
 
 
 Pain Management Algorithm 
  
Continue to assess Q 2 hours 
and PRN 
Pain Management 
 
- Opioid and/or non-opioid 
analgesic 
- Non-pharmacological 
strategies 
 
Pain Management 
 
- Non-pharmacological 
strategies 
- Discuss Non-opioid 
analgesics with provider 
NRS = 0 
CPOT = 0 
NRS = 1-3 
CPOT = 1-2 
NRS > 3 
CPOT > 2 
Severe 
NRS: 7-10 
CPOT: 6-8 
 
Moderate 
NRS: 4-6 
CPOT: 3-5 
Pain Reassessment 
(within) 
 
- IV/IM: 15 to 30 minutes 
 
- PO: 1 hour  
 
- Non-pharmacological 
strategies: 1 hour 
 
 
Intervention?   YES 
Intervention?   NO 
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Analgesic Order Sets 
 
Fentanyl Infusion & PRN Bolus Order Set 
Start Fentanyl drip at: 
 Low dose regiment = 25 mcg/hr 
 High dose regiment = 50 mcg/hr  
 Provider determined dose 
  
Comments: 
1) PRN bolus for break through pain CPOT > 2 
 CPOT 3-5 (moderate pain) = Fentanyl IV 25 mcg Q 10 min 
 CPOT 6-8 (severe pain) = Fentanyl IV 50 mcg Q 10 min 
 *** 3 maximum total boluses within 1 hour (regardless of dose) 
 
2) Titration: 
 Increase infusion rate by 50 mcg/hr if ≥ 3 boluses are required for break through pain  
      within 1 hour. 
 Notify provider for all infusion rate increases. 
 Reduce infusion rate daily per sedation wake-up protocol. 
 
 
PRN Hydromorphone Order Set 
1. CPOT > 2: give 0.2 mg x 1 hydromorphone IV 
2. Wait 5 mins 
3. CPOT > 2: give 0.4 mg x 1 hydromorphone IV 
4. Wait 5 mins 
5. CPOT > 2: give 0.8 mg x 1 hydromorphone IV 
6. *If patient required(received) 3 consecutive doses (total 1.4 mg) with in 1 hour 
(consider)scheduled oxycodone 
 
Figure 2. 
